Misconceptions and Facts about Atrial Fibrillation

American Journal of Medicine

Volumn 128, Issue 9, 2015, Pages 938-942

  Argulian, Edgar ^a   Conen, David ^b   Messerli, Franz H ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Atrial fibrillation; Ischemic stroke; Novel oral anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ALCOHOL CONSUMPTION; ASYMPTOMATIC DISEASE; ATRIAL FIBRILLATION; BLEEDING TENDENCY; CARDIOEMBOLIC STROKE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CHA2 DS2 VASC SCORE; CLINICAL OBSERVATION; CLINICAL TRIAL (TOPIC); DRUG CONTRAINDICATION; EXERCISE; HIGH RISK PATIENT; HUMAN; LETTER; LOW RISK PATIENT; META ANALYSIS (TOPIC); PAROXYSMAL ATRIAL FIBRILLATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; VALVULAR HEART DISEASE; ADVERSE EFFECTS; CARDIOVASCULAR DISEASE; COMPLICATION; DRINKING BEHAVIOR; MOTOR ACTIVITY; ORAL DRUG ADMINISTRATION; RISK FACTOR; STROKE;

ADMINISTRATION, ORAL; ALCOHOL DRINKING; ANTICOAGULANTS; ASPIRIN; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; HUMANS; MOTOR ACTIVITY; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84946747442     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.02.016     Document Type: Review

References (49)

1. J. Andrade, P. Khairy, D. Dobrev, and S. Nattel The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms Circ Res 114 9 2014 1453 1468
2. J.S. Alpert Atrial fibrillation: a growth industry in the 21st century Eur Heart J 21 15 2000 1207 1208
3. D.G. Wyse, I.C. Van Gelder, P.T. Ellinor, and et al. Lone atrial fibrillation: does it exist? J Am Coll Cardiol 63 17 2014 1715 1723
4. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 21 2014 e1 e76
5. L. Mont, D. Tamborero, R. Elosua, and et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals Europace 10 1 2008 15 20
6. P. Ofman, O. Khawaja, C.R. Rahilly-Tierney, and et al. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis Circ Arrhythm Electrophysiol 6 2 2013 252 256
7. D. Mozaffarian, C.D. Furberg, B.M. Psaty, and D. Siscovick Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study Circulation 118 8 2008 800 807
8. P.O. Ettinger, C.F. Wu, C. De La Cruz Jr., and et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders Am Heart J 95 5 1978 555 562
9. J.R. Thornton Atrial fibrillation in healthy non-alcoholic people after an alcoholic binge Lancet 2 8410 1984 1013 1015
10. L. Djousse, D. Levy, E.J. Benjamin, and et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study Am J Cardiol 93 6 2004 710 713
11. D. Conen, U.B. Tedrow, N.R. Cook, and et al. Alcohol consumption and risk of incident atrial fibrillation in women JAMA 300 21 2008 2489 2496
12. K.J. Mukamal, J.S. Tolstrup, J. Friberg, and et al. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study Circulation 112 12 2005 1736 1742
13. S.C. Larsson, N. Drca, and A. Wolk Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis J Am Coll Cardiol 64 3 2014 281 289
14. D. Conen, and C.M. Albert Alcohol consumption and risk of atrial fibrillation: how much is too much? J Am Coll Cardiol 64 3 2014 290 292
15. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 21 2014 2246 2280
16. R. De Caterina, and A.J. Camm What is 'valvular' atrial fibrillation? A reappraisal Eur Heart J 35 47 2014 3328 3335
17. K.H. Olesen The natural history of 271 patients with mitral stenosis under medical treatment Br Heart J 24 1962 349 357
18. Y. Wada, K. Mizushige, K. Ohmori, and et al. Prevention of cerebral thromboembolism by low-dose anticoagulant therapy in atrial fibrillation with mitral regurgitation J Cardiovasc Pharmacol 37 4 2001 422 426
19. H. Nakagami, K. Yamamoto, U. Ikeda, and et al. Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation Am Heart J 136 3 1998 528 532
20. G. Breithardt, H. Baumgartner, S.D. Berkowitz, and et al. Clinical characteristics and outcomes with rivaroxaban vs. Warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial Eur Heart J 35 47 2014 3377 3385
21. J.W. Eikelboom, S.J. Connolly, M. Brueckmann, and et al. Dabigatran versus warfarin in patients with mechanical heart valves N Engl J Med 369 13 2013 1206 1214
22. J.M. Leyden, T.J. Kleinig, J. Newbury, and et al. Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes Stroke 44 5 2013 1226 1231
23. D.J. Gladstone, E. Bui, J. Fang, and et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated Stroke 40 1 2009 235 240
24. Y. Schwammenthal, N. Bornstein, E. Schwammenthal, and et al. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]) Am J Cardiol 105 3 2010 411 416
25. S.B. Freedman, B.J. Gersh, and G.Y. Lip Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation Eur Heart J 36 11 2015 653 656
26. Stroke Prevention in Atrial Fibrillation Study Final results Circulation 84 2 1991 527 539
27. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 12 2007 857 867
28. J.B. Olesen, G.Y. Lip, J. Lindhardsen, and et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 4 2011 739 749
29. C. van Walraven, R.G. Hart, S. Connolly, and et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators Stroke 40 4 2009 1410 1416
30. J. Mant, F.D. Hobbs, K. Fletcher, and et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 9586 2007 493 503
31. S.J. Connolly, J. Eikelboom, C. Joyner, and et al. Apixaban in patients with atrial fibrillation N Engl J Med 364 9 2011 806 817
32. D.E. Singer, and M.D. Ezekowitz Adding rigor to stroke risk prediction in atrial fibrillation J Am Coll Cardiol 65 3 2015 233 235
33. A.J. Camm, G.Y. Lip, R. De Caterina, and et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 21 2012 2719 2747
34. J.B. Olesen, G.Y. Lip, M.L. Hansen, and et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
35. L. Friberg, M. Skeppholm, and A. Terent Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1 J Am Coll Cardiol 65 3 2015 225 232
36. T.F. Chao, C.J. Liu, K.L. Wang, and et al. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol 65 7 2015 635 642
37. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 33 12 2012 1500 1510
38. Z. Hijazi, L. Wallentin, A. Siegbahn, and et al. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation) J Am Coll Cardiol 61 22 2013 2274 2284
39. G.Y. Lip Bleeding risk assessment and management in atrial fibrillation patients Eur Heart J 33 2 2012 147 149
40. J.S. Alpert Atrial fibrillation: food for thought in 2013 Am J Med 126 11 2013 937 938
41. P. Petersen, and J. Godtfredsen Embolic complications in paroxysmal atrial fibrillation Stroke 17 4 1986 622 626
42. W.B. Kannel, R.D. Abbott, D.D. Savage, and P.M. McNamara Coronary heart disease and atrial fibrillation: the Framingham Study Am Heart J 106 2 1983 389 396
43. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 13 1994 1449 1457
44. T. Vanassche, M.N. Lauw, J.W. Eikelboom, and et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES Eur Heart J 36 5 2015 281 288
45. S.M. Al-Khatib, L. Thomas, L. Wallentin, and et al. Outcomes of apixaban vs. Warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial Eur Heart J 34 31 2013 2464 2471
46. P.G. Platonov, L.B. Mitrofanova, V. Orshanskaya, and S.Y. Ho Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age J Am Coll Cardiol 58 21 2011 2225 2232
47. C.W. Israel, G. Gronefeld, J.R. Ehrlich, and et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J Am Coll Cardiol 43 1 2004 47 52
48. J.S. Healey, S.J. Connolly, M.R. Gold, and et al. Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2 2012 120 129
49. N. Shanmugam, A. Boerdlein, J. Proff, and et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population Europace 14 2 2012 230 237